Aristotle Atlantic Partners, LLC Becton Dickinson & CO Transaction History

Aristotle Atlantic Partners, LLC

  • $3.19 Billion
  • Q3 2024

A detailed history of Aristotle Atlantic Partners, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Aristotle Atlantic Partners, LLC holds 83,087 shares of BDX stock, worth $19 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
83,087
Previous 80,505 3.21%
Holding current value
$19 Million
Previous $18.8 Million 6.47%
% of portfolio
0.63%
Previous 0.61%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$221.47 - $242.41 $571,835 - $625,902
2,582 Added 3.21%
83,087 $20 Million
Q2 2024

Aug 14, 2024
SELL
$225.07 - $246.17 $2.63 Million - $2.88 Million
-11,696 Reduced 12.69%
80,505 $18.8 Million
Q1 2024

May 15, 2024
SELL
$233.45 - $247.73 $8.37 Million - $8.88 Million
-35,854 Reduced 28.0%
92,201 $22.8 Million
Q4 2023

Feb 14, 2024
BUY
$232.24 - $267.23 $8,128 - $9,353
35 Added 0.03%
128,055 $31.2 Million
Q3 2023

Nov 14, 2023
SELL
$254.9 - $283.59 $870,228 - $968,176
-3,414 Reduced 2.6%
128,020 $33.1 Million
Q2 2023

Aug 14, 2023
BUY
$238.39 - $265.32 $8.87 Million - $9.87 Million
37,219 Added 39.5%
131,434 $34.7 Million
Q1 2023

May 15, 2023
BUY
$229.71 - $259.35 $2.09 Million - $2.36 Million
9,110 Added 10.7%
94,215 $23.3 Million
Q4 2022

Feb 14, 2023
BUY
$218.29 - $256.91 $649,194 - $764,050
2,974 Added 3.62%
85,105 $21.6 Million
Q3 2022

Nov 14, 2022
BUY
$51.03 - $264.23 $2.37 Million - $12.3 Million
46,470 Added 130.31%
82,131 $18.3 Million
Q2 2022

Aug 15, 2022
BUY
$234.74 - $275.42 $4.14 Million - $4.85 Million
17,619 Added 97.66%
35,661 $8.79 Million
Q1 2022

May 16, 2022
BUY
$243.64 - $270.48 $230,727 - $256,144
947 Added 5.54%
18,042 $4.8 Million
Q4 2021

Feb 14, 2022
BUY
$230.08 - $250.94 $567,377 - $618,818
2,466 Added 16.86%
17,095 $4.3 Million
Q3 2021

Nov 15, 2021
SELL
$232.72 - $256.47 $1.31 Million - $1.45 Million
-5,645 Reduced 27.84%
14,629 $3.6 Million
Q2 2021

Aug 16, 2021
BUY
$232.65 - $254.58 $286,624 - $313,642
1,232 Added 6.47%
20,274 $4.93 Million
Q1 2021

May 17, 2021
BUY
$232.09 - $256.88 $429,598 - $475,484
1,851 Added 10.77%
19,042 $4.63 Million
Q4 2020

Feb 16, 2021
BUY
$221.92 - $245.94 $389,247 - $431,378
1,754 Added 11.36%
17,191 $4.3 Million
Q3 2020

Nov 16, 2020
BUY
$215.77 - $276.76 $871,926 - $1.12 Million
4,041 Added 35.46%
15,437 $3.59 Million
Q2 2020

Aug 14, 2020
BUY
$219.9 - $263.41 $604,944 - $724,640
2,751 Added 31.82%
11,396 $2.73 Million
Q1 2020

May 14, 2020
BUY
$195.69 - $279.01 $114,282 - $162,941
584 Added 7.24%
8,645 $1.99 Million
Q4 2019

Feb 13, 2020
BUY
$236.45 - $266.82 $197,672 - $223,061
836 Added 11.57%
8,061 $2.19 Million
Q3 2019

Nov 14, 2019
BUY
$230.58 - $256.08 $165,556 - $183,865
718 Added 11.03%
7,225 $1.83 Million
Q2 2019

Aug 13, 2019
BUY
$217.4 - $246.08 $153,701 - $173,978
707 Added 12.19%
6,507 $1.64 Million
Q1 2019

May 15, 2019
BUY
$206.05 - $248.17 $4,327 - $5,211
21 Added 0.36%
5,800 $1.45 Million
Q4 2018

Feb 13, 2019
BUY
$204.73 - $257.93 $1.18 Million - $1.49 Million
5,779 New
5,779 $1.3 Million
Q3 2018

Nov 14, 2018
SELL
$233.07 - $256.0 $1.02 Million - $1.12 Million
-4,360 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$208.1 - $233.85 $149,623 - $168,138
719 Added 19.75%
4,360 $1.05 Million
Q1 2018

Sep 10, 2018
BUY
$205.46 - $240.27 $8,012 - $9,370
39 Added 1.08%
3,641 $789,000
Q1 2018

May 14, 2018
BUY
$205.46 - $240.27 $332,023 - $388,276
1,616 Added 81.37%
3,602 $781,000
Q4 2017

Feb 14, 2018
BUY
$189.0 - $222.64 $375,354 - $442,163
1,986
1,986 $425,000

Others Institutions Holding BDX

# of Institutions
1,738
Shares Held
249M
Call Options Held
690K
Put Options Held
787K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Aristotle Atlantic Partners, LLC Portfolio

Follow Aristotle Atlantic Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Atlantic Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Atlantic Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email